These findings led us to the conclusion that efficacy of SLC-0111 is very much dependent on the expression status of CAIX and CAXII in the tumor mass as LOVO and SW48 cells showed little to no expression of neither CAIX nor CAXII in both spheroids and xenograft tumors. This evidence concerns the gene CA12 and neoplasm.